Mingyue Optical LensLtd's (SZSE:301101) Profits Appear To Have Quality Issues
Mingyue Optical Lens: Half-year report for the year 2024.
Mingyue Optical Lens: Summary of Half-Year Report in 2024.
Mingyue Optics (301101.SZ): The net income in the first half of the year was 88.9667 million yuan, a year-on-year increase of 11.04%.
Mingyue Lens (301101.SZ) released its semi-annual report today. The revenue was 0.385 billion yuan, which increased by 5.21% YoY. The net income was 88.9667 million yuan, which increased by 11.04% YoY. The non-GAAP net income was 75.498 million yuan, which increased by 7.12% YoY. The eps was 0.4415 yuan.
Is Mingyue Optical Lens Co.,Ltd.'s (SZSE:301101) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Mingyue Lens (301101.SZ): Mainly produces lens products for daily consumer wear.
Mingyue Lens (301101.SZ) stated on the investor interaction platform on July 30 that the company's main business is consumer daily wear lens products, with functions covering anti-blue light, ultra-bright, ultra-tough, intelligent color changing, myopia prevention and control, progressive multi-focus, polarization, etc.
Mingyue Lens (301101.SZ): The Asia Vets smart glasses Sasky have a voice assistant function and can wake up SIRI and Xiaoai with voice commands.
Mingyue Lens (301101.SZ) stated on the investor interaction platform on July 30th that the intelligent glasses sasky sold at the flagship stores of Tmall, JD.com and Xiaomi's Youpin have voice assistant function, and can voice wake up SIRI and Xiao Ai students. It also has functions such as making and receiving calls, navigation, music and leisure. The company is actively focusing on forward-looking technology in the eyewear industry while maintaining its core business.
Subdued Growth No Barrier To Mingyue Optical Lens Co.,Ltd.'s (SZSE:301101) Price
Mingyue Lens (301101.SZ) announces a profit increase, with a net income of 83.5466 million yuan to 92.8295 million yuan in the first half of the year, a year-on-year increase of 4.28% to 15.86%.
Mingyue Lens (301101.SZ) announced its half-year performance forecast for 2024, with the company expected to generate Net profit attributable to shareholders of the listed company...
Mingyue Optical Lens: 2024 Interim Performance Forecast
Mingyue Optical Lens Co.,Ltd.'s (SZSE:301101) Market Cap Dropped CN¥420m Last Week; Private Companies Bore the Brunt
Mingyue Lens (301101.SZ): 2023 equity distribution 10 distribution 3 yuan share registration date May 27
Gelonghui May 20 | Mingyue Lens (301101.SZ) announced that the company's 2023 equity distribution plan is to distribute cash dividends of RMB 3.00 (tax included) to all shareholders for every 10 shares based on the total share capital after deducting the total share capital of 200,732,618 shares after 779,482 shares have been repurchased in the company's special repurchase account. The share registration date for this equity distribution is May 27, 2024, and the ex-dividend date is May 28, 2024.
Moonlight Lens (301101.SZ): No contact lenses have been produced
Gelonghui, April 24 | Mingyue Lens (301101.SZ) said on the interactive platform that the company currently does not produce contact lenses. High-end optical resin lenses are the company's core products, and lens products are mainly based on its own well-known brand “Mingyue”. According to authoritative market research data published by the internationally renowned market research agency Frost & Sullivan (hereinafter referred to as “Sullivan”), in the retail pattern of the Chinese brand lens industry in 2023, in terms of retail volume, Mingyue Lens ranked first with a market share of 12.4%.
Mingyue Lens (301101.SZ) reported 2023 annual results with net profit of 158 million yuan, an increase of 15.65% over the previous year
Mingyue Lens (301101.SZ) released its 2023 annual report. The company achieved operating income of 7 during the reporting period...
Mingyue Optical Lens Co.,Ltd. (SZSE:301101) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Mingyue Lens (301101.SZ): Plans to postpone the “High-end Resin Lens Production Expansion Project”
Gelonghui, March 19, 丨 Mingyue Lens (301101.SZ) announced that the company held the 12th meeting of the 2nd board of directors and the 12th meeting of the 2nd board of supervisors on March 19, 2024 to separately review and pass the “Proposal on the Extension of Partial Fund-raising Projects”, agreeing that the company will adjust the scheduled usage status of the “High-end Resin Lens Expansion Project” on the premise that the implementation entity, implementation method, construction content, investment use of capital raised and investment scale of the fund-raising project will not change. The 20th of the month.
The Returns On Capital At Mingyue Optical LensLtd (SZSE:301101) Don't Inspire Confidence
Risks To Shareholder Returns Are Elevated At These Prices For Mingyue Optical Lens Co.,Ltd. (SZSE:301101)
Mingyue Lens (301101.SZ): Plans to jointly invest in Huhu Health Technology with related parties
Gelonghui, January 24, 丨 Mingyue Lens (301101.SZ) announced that the company held the 11th meeting of the 2nd board of directors and the 11th meeting of the 2nd board of supervisors on January 24, 2024 to review and pass the “Proposal on Joint Investment in Huhu Health Technology and Related Transactions with Related Parties”, and agreed that the company plans to sign the “Investment Agreement on Huhu Health Technology (Hangzhou) Co., Ltd.” with its own capital of 6 million yuan (holding 11.32% of shares), the company's affiliate Shanghai Mingyue Industrial Co., Ltd. (hereinafter referred to as “Mingyue” “Industry”) with own funds3
Institutions Profited After Mingyue Optical Lens Co.,Ltd.'s (SZSE:301101) Market Cap Rose CN¥596m Last Week but Private Companies Profited the Most
No Data
No Data